Global Needle-Free Drug Injection Systems Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Needle-Free Drug Injection Systems market size was valued at US$ 9481.2 million in 2023. With growing demand in downstream market, the Needle-Free Drug Injection Systems is forecast to a readjusted size of US$ 16520 million by 2030 with a CAGR of 8.3% during review period.
The research report highlights the growth potential of the global Needle-Free Drug Injection Systems market. Needle-Free Drug Injection Systems are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Needle-Free Drug Injection Systems. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Needle-Free Drug Injection Systems market.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Needle-Free Drug Injection Systems market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Needle-Free Drug Injection Systems market. It may include historical data, market segmentation by Type (e.g., Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Needle-Free Drug Injection Systems market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Needle-Free Drug Injection Systems market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Needle-Free Drug Injection Systems industry. This include advancements in Needle-Free Drug Injection Systems technology, Needle-Free Drug Injection Systems new entrants, Needle-Free Drug Injection Systems new investment, and other innovations that are shaping the future of Needle-Free Drug Injection Systems.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Needle-Free Drug Injection Systems market. It includes factors influencing customer ' purchasing decisions, preferences for Needle-Free Drug Injection Systems product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Needle-Free Drug Injection Systems market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Needle-Free Drug Injection Systems market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Needle-Free Drug Injection Systems market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Needle-Free Drug Injection Systems industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Needle-Free Drug Injection Systems market.
Market Segmentation:
Needle-Free Drug Injection Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Needle-Free Drug Injection Systems market?
What factors are driving Needle-Free Drug Injection Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Needle-Free Drug Injection Systems market opportunities vary by end market size?
How does Needle-Free Drug Injection Systems break out type, application?
According to our LPI (LP Information) latest study, the global Needle-Free Drug Injection Systems market size was valued at US$ 9481.2 million in 2023. With growing demand in downstream market, the Needle-Free Drug Injection Systems is forecast to a readjusted size of US$ 16520 million by 2030 with a CAGR of 8.3% during review period.
The research report highlights the growth potential of the global Needle-Free Drug Injection Systems market. Needle-Free Drug Injection Systems are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Needle-Free Drug Injection Systems. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Needle-Free Drug Injection Systems market.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Needle-Free Drug Injection Systems market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Needle-Free Drug Injection Systems market. It may include historical data, market segmentation by Type (e.g., Jet-Based Needle-Free Injectors, Spring-Based Needle-Free Injectors), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Needle-Free Drug Injection Systems market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Needle-Free Drug Injection Systems market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Needle-Free Drug Injection Systems industry. This include advancements in Needle-Free Drug Injection Systems technology, Needle-Free Drug Injection Systems new entrants, Needle-Free Drug Injection Systems new investment, and other innovations that are shaping the future of Needle-Free Drug Injection Systems.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Needle-Free Drug Injection Systems market. It includes factors influencing customer ' purchasing decisions, preferences for Needle-Free Drug Injection Systems product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Needle-Free Drug Injection Systems market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Needle-Free Drug Injection Systems market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Needle-Free Drug Injection Systems market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Needle-Free Drug Injection Systems industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Needle-Free Drug Injection Systems market.
Market Segmentation:
Needle-Free Drug Injection Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Jet-Based Needle-Free Injectors
- Spring-Based Needle-Free Injectors
- Laser-Powered Needle-Free Injectors
- Vibration-Based Needle-Free Injectors
- Hospitals and Clinics
- Homecare Settings
- Research Laboratories
- Pharmaceutical and Biotechnology companies
- Other End Users
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Antares Pharma, Inc. (US)
- Endo International plc (US)
- PharmaJet (U.S)
- Bioject Medical Technologies Inc. (U.S)
- Medical International Technology, Inc. (U.S)
- INJEX Pharma AG (Germany)
- National Medical Products Inc. (US)
- Valeritas, Inc. (US)
- European Pharma Group (Netherland)
- PenJet Corporation (U.S)
- Crossject SA (France)
What is the 10-year outlook for the global Needle-Free Drug Injection Systems market?
What factors are driving Needle-Free Drug Injection Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Needle-Free Drug Injection Systems market opportunities vary by end market size?
How does Needle-Free Drug Injection Systems break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Needle-Free Drug Injection Systems Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Needle-Free Drug Injection Systems by Country/Region, 2019, 2023 & 2030
2.2 Needle-Free Drug Injection Systems Segment by Type
2.2.1 Jet-Based Needle-Free Injectors
2.2.2 Spring-Based Needle-Free Injectors
2.2.3 Laser-Powered Needle-Free Injectors
2.2.4 Vibration-Based Needle-Free Injectors
2.3 Needle-Free Drug Injection Systems Sales by Type
2.3.1 Global Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
2.3.2 Global Needle-Free Drug Injection Systems Revenue and Market Share by Type (2019-2024)
2.3.3 Global Needle-Free Drug Injection Systems Sale Price by Type (2019-2024)
2.4 Needle-Free Drug Injection Systems Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Homecare Settings
2.4.3 Research Laboratories
2.4.4 Pharmaceutical and Biotechnology companies
2.4.5 Other End Users
2.5 Needle-Free Drug Injection Systems Sales by Application
2.5.1 Global Needle-Free Drug Injection Systems Sale Market Share by Application (2019-2024)
2.5.2 Global Needle-Free Drug Injection Systems Revenue and Market Share by Application (2019-2024)
2.5.3 Global Needle-Free Drug Injection Systems Sale Price by Application (2019-2024)
3 GLOBAL NEEDLE-FREE DRUG INJECTION SYSTEMS BY COMPANY
3.1 Global Needle-Free Drug Injection Systems Breakdown Data by Company
3.1.1 Global Needle-Free Drug Injection Systems Annual Sales by Company (2019-2024)
3.1.2 Global Needle-Free Drug Injection Systems Sales Market Share by Company (2019-2024)
3.2 Global Needle-Free Drug Injection Systems Annual Revenue by Company (2019-2024)
3.2.1 Global Needle-Free Drug Injection Systems Revenue by Company (2019-2024)
3.2.2 Global Needle-Free Drug Injection Systems Revenue Market Share by Company (2019-2024)
3.3 Global Needle-Free Drug Injection Systems Sale Price by Company
3.4 Key Manufacturers Needle-Free Drug Injection Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Needle-Free Drug Injection Systems Product Location Distribution
3.4.2 Players Needle-Free Drug Injection Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEEDLE-FREE DRUG INJECTION SYSTEMS BY GEOGRAPHIC REGION
4.1 World Historic Needle-Free Drug Injection Systems Market Size by Geographic Region (2019-2024)
4.1.1 Global Needle-Free Drug Injection Systems Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Needle-Free Drug Injection Systems Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Needle-Free Drug Injection Systems Market Size by Country/Region (2019-2024)
4.2.1 Global Needle-Free Drug Injection Systems Annual Sales by Country/Region (2019-2024)
4.2.2 Global Needle-Free Drug Injection Systems Annual Revenue by Country/Region (2019-2024)
4.3 Americas Needle-Free Drug Injection Systems Sales Growth
4.4 APAC Needle-Free Drug Injection Systems Sales Growth
4.5 Europe Needle-Free Drug Injection Systems Sales Growth
4.6 Middle East & Africa Needle-Free Drug Injection Systems Sales Growth
5 AMERICAS
5.1 Americas Needle-Free Drug Injection Systems Sales by Country
5.1.1 Americas Needle-Free Drug Injection Systems Sales by Country (2019-2024)
5.1.2 Americas Needle-Free Drug Injection Systems Revenue by Country (2019-2024)
5.2 Americas Needle-Free Drug Injection Systems Sales by Type
5.3 Americas Needle-Free Drug Injection Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Needle-Free Drug Injection Systems Sales by Region
6.1.1 APAC Needle-Free Drug Injection Systems Sales by Region (2019-2024)
6.1.2 APAC Needle-Free Drug Injection Systems Revenue by Region (2019-2024)
6.2 APAC Needle-Free Drug Injection Systems Sales by Type
6.3 APAC Needle-Free Drug Injection Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Needle-Free Drug Injection Systems by Country
7.1.1 Europe Needle-Free Drug Injection Systems Sales by Country (2019-2024)
7.1.2 Europe Needle-Free Drug Injection Systems Revenue by Country (2019-2024)
7.2 Europe Needle-Free Drug Injection Systems Sales by Type
7.3 Europe Needle-Free Drug Injection Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Needle-Free Drug Injection Systems by Country
8.1.1 Middle East & Africa Needle-Free Drug Injection Systems Sales by Country (2019-2024)
8.1.2 Middle East & Africa Needle-Free Drug Injection Systems Revenue by Country (2019-2024)
8.2 Middle East & Africa Needle-Free Drug Injection Systems Sales by Type
8.3 Middle East & Africa Needle-Free Drug Injection Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Needle-Free Drug Injection Systems
10.3 Manufacturing Process Analysis of Needle-Free Drug Injection Systems
10.4 Industry Chain Structure of Needle-Free Drug Injection Systems
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Needle-Free Drug Injection Systems Distributors
11.3 Needle-Free Drug Injection Systems Customer
12 WORLD FORECAST REVIEW FOR NEEDLE-FREE DRUG INJECTION SYSTEMS BY GEOGRAPHIC REGION
12.1 Global Needle-Free Drug Injection Systems Market Size Forecast by Region
12.1.1 Global Needle-Free Drug Injection Systems Forecast by Region (2025-2030)
12.1.2 Global Needle-Free Drug Injection Systems Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Needle-Free Drug Injection Systems Forecast by Type
12.7 Global Needle-Free Drug Injection Systems Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Antares Pharma, Inc. (US)
13.1.1 Antares Pharma, Inc. (US) Company Information
13.1.2 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.1.3 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Antares Pharma, Inc. (US) Main Business Overview
13.1.5 Antares Pharma, Inc. (US) Latest Developments
13.2 Endo International plc (US)
13.2.1 Endo International plc (US) Company Information
13.2.2 Endo International plc (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.2.3 Endo International plc (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Endo International plc (US) Main Business Overview
13.2.5 Endo International plc (US) Latest Developments
13.3 PharmaJet (U.S)
13.3.1 PharmaJet (U.S) Company Information
13.3.2 PharmaJet (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.3.3 PharmaJet (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 PharmaJet (U.S) Main Business Overview
13.3.5 PharmaJet (U.S) Latest Developments
13.4 Bioject Medical Technologies Inc. (U.S)
13.4.1 Bioject Medical Technologies Inc. (U.S) Company Information
13.4.2 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.4.3 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bioject Medical Technologies Inc. (U.S) Main Business Overview
13.4.5 Bioject Medical Technologies Inc. (U.S) Latest Developments
13.5 Medical International Technology, Inc. (U.S)
13.5.1 Medical International Technology, Inc. (U.S) Company Information
13.5.2 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.5.3 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Medical International Technology, Inc. (U.S) Main Business Overview
13.5.5 Medical International Technology, Inc. (U.S) Latest Developments
13.6 INJEX Pharma AG (Germany)
13.6.1 INJEX Pharma AG (Germany) Company Information
13.6.2 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.6.3 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 INJEX Pharma AG (Germany) Main Business Overview
13.6.5 INJEX Pharma AG (Germany) Latest Developments
13.7 National Medical Products Inc. (US)
13.7.1 National Medical Products Inc. (US) Company Information
13.7.2 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.7.3 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 National Medical Products Inc. (US) Main Business Overview
13.7.5 National Medical Products Inc. (US) Latest Developments
13.8 Valeritas, Inc. (US)
13.8.1 Valeritas, Inc. (US) Company Information
13.8.2 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.8.3 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Valeritas, Inc. (US) Main Business Overview
13.8.5 Valeritas, Inc. (US) Latest Developments
13.9 European Pharma Group (Netherland)
13.9.1 European Pharma Group (Netherland) Company Information
13.9.2 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.9.3 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 European Pharma Group (Netherland) Main Business Overview
13.9.5 European Pharma Group (Netherland) Latest Developments
13.10 PenJet Corporation (U.S)
13.10.1 PenJet Corporation (U.S) Company Information
13.10.2 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.10.3 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 PenJet Corporation (U.S) Main Business Overview
13.10.5 PenJet Corporation (U.S) Latest Developments
13.11 Crossject SA (France)
13.11.1 Crossject SA (France) Company Information
13.11.2 Crossject SA (France) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.11.3 Crossject SA (France) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Crossject SA (France) Main Business Overview
13.11.5 Crossject SA (France) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Needle-Free Drug Injection Systems Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Needle-Free Drug Injection Systems by Country/Region, 2019, 2023 & 2030
2.2 Needle-Free Drug Injection Systems Segment by Type
2.2.1 Jet-Based Needle-Free Injectors
2.2.2 Spring-Based Needle-Free Injectors
2.2.3 Laser-Powered Needle-Free Injectors
2.2.4 Vibration-Based Needle-Free Injectors
2.3 Needle-Free Drug Injection Systems Sales by Type
2.3.1 Global Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
2.3.2 Global Needle-Free Drug Injection Systems Revenue and Market Share by Type (2019-2024)
2.3.3 Global Needle-Free Drug Injection Systems Sale Price by Type (2019-2024)
2.4 Needle-Free Drug Injection Systems Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Homecare Settings
2.4.3 Research Laboratories
2.4.4 Pharmaceutical and Biotechnology companies
2.4.5 Other End Users
2.5 Needle-Free Drug Injection Systems Sales by Application
2.5.1 Global Needle-Free Drug Injection Systems Sale Market Share by Application (2019-2024)
2.5.2 Global Needle-Free Drug Injection Systems Revenue and Market Share by Application (2019-2024)
2.5.3 Global Needle-Free Drug Injection Systems Sale Price by Application (2019-2024)
3 GLOBAL NEEDLE-FREE DRUG INJECTION SYSTEMS BY COMPANY
3.1 Global Needle-Free Drug Injection Systems Breakdown Data by Company
3.1.1 Global Needle-Free Drug Injection Systems Annual Sales by Company (2019-2024)
3.1.2 Global Needle-Free Drug Injection Systems Sales Market Share by Company (2019-2024)
3.2 Global Needle-Free Drug Injection Systems Annual Revenue by Company (2019-2024)
3.2.1 Global Needle-Free Drug Injection Systems Revenue by Company (2019-2024)
3.2.2 Global Needle-Free Drug Injection Systems Revenue Market Share by Company (2019-2024)
3.3 Global Needle-Free Drug Injection Systems Sale Price by Company
3.4 Key Manufacturers Needle-Free Drug Injection Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Needle-Free Drug Injection Systems Product Location Distribution
3.4.2 Players Needle-Free Drug Injection Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR NEEDLE-FREE DRUG INJECTION SYSTEMS BY GEOGRAPHIC REGION
4.1 World Historic Needle-Free Drug Injection Systems Market Size by Geographic Region (2019-2024)
4.1.1 Global Needle-Free Drug Injection Systems Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Needle-Free Drug Injection Systems Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Needle-Free Drug Injection Systems Market Size by Country/Region (2019-2024)
4.2.1 Global Needle-Free Drug Injection Systems Annual Sales by Country/Region (2019-2024)
4.2.2 Global Needle-Free Drug Injection Systems Annual Revenue by Country/Region (2019-2024)
4.3 Americas Needle-Free Drug Injection Systems Sales Growth
4.4 APAC Needle-Free Drug Injection Systems Sales Growth
4.5 Europe Needle-Free Drug Injection Systems Sales Growth
4.6 Middle East & Africa Needle-Free Drug Injection Systems Sales Growth
5 AMERICAS
5.1 Americas Needle-Free Drug Injection Systems Sales by Country
5.1.1 Americas Needle-Free Drug Injection Systems Sales by Country (2019-2024)
5.1.2 Americas Needle-Free Drug Injection Systems Revenue by Country (2019-2024)
5.2 Americas Needle-Free Drug Injection Systems Sales by Type
5.3 Americas Needle-Free Drug Injection Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Needle-Free Drug Injection Systems Sales by Region
6.1.1 APAC Needle-Free Drug Injection Systems Sales by Region (2019-2024)
6.1.2 APAC Needle-Free Drug Injection Systems Revenue by Region (2019-2024)
6.2 APAC Needle-Free Drug Injection Systems Sales by Type
6.3 APAC Needle-Free Drug Injection Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Needle-Free Drug Injection Systems by Country
7.1.1 Europe Needle-Free Drug Injection Systems Sales by Country (2019-2024)
7.1.2 Europe Needle-Free Drug Injection Systems Revenue by Country (2019-2024)
7.2 Europe Needle-Free Drug Injection Systems Sales by Type
7.3 Europe Needle-Free Drug Injection Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Needle-Free Drug Injection Systems by Country
8.1.1 Middle East & Africa Needle-Free Drug Injection Systems Sales by Country (2019-2024)
8.1.2 Middle East & Africa Needle-Free Drug Injection Systems Revenue by Country (2019-2024)
8.2 Middle East & Africa Needle-Free Drug Injection Systems Sales by Type
8.3 Middle East & Africa Needle-Free Drug Injection Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Needle-Free Drug Injection Systems
10.3 Manufacturing Process Analysis of Needle-Free Drug Injection Systems
10.4 Industry Chain Structure of Needle-Free Drug Injection Systems
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Needle-Free Drug Injection Systems Distributors
11.3 Needle-Free Drug Injection Systems Customer
12 WORLD FORECAST REVIEW FOR NEEDLE-FREE DRUG INJECTION SYSTEMS BY GEOGRAPHIC REGION
12.1 Global Needle-Free Drug Injection Systems Market Size Forecast by Region
12.1.1 Global Needle-Free Drug Injection Systems Forecast by Region (2025-2030)
12.1.2 Global Needle-Free Drug Injection Systems Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Needle-Free Drug Injection Systems Forecast by Type
12.7 Global Needle-Free Drug Injection Systems Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Antares Pharma, Inc. (US)
13.1.1 Antares Pharma, Inc. (US) Company Information
13.1.2 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.1.3 Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Antares Pharma, Inc. (US) Main Business Overview
13.1.5 Antares Pharma, Inc. (US) Latest Developments
13.2 Endo International plc (US)
13.2.1 Endo International plc (US) Company Information
13.2.2 Endo International plc (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.2.3 Endo International plc (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Endo International plc (US) Main Business Overview
13.2.5 Endo International plc (US) Latest Developments
13.3 PharmaJet (U.S)
13.3.1 PharmaJet (U.S) Company Information
13.3.2 PharmaJet (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.3.3 PharmaJet (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 PharmaJet (U.S) Main Business Overview
13.3.5 PharmaJet (U.S) Latest Developments
13.4 Bioject Medical Technologies Inc. (U.S)
13.4.1 Bioject Medical Technologies Inc. (U.S) Company Information
13.4.2 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.4.3 Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bioject Medical Technologies Inc. (U.S) Main Business Overview
13.4.5 Bioject Medical Technologies Inc. (U.S) Latest Developments
13.5 Medical International Technology, Inc. (U.S)
13.5.1 Medical International Technology, Inc. (U.S) Company Information
13.5.2 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.5.3 Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Medical International Technology, Inc. (U.S) Main Business Overview
13.5.5 Medical International Technology, Inc. (U.S) Latest Developments
13.6 INJEX Pharma AG (Germany)
13.6.1 INJEX Pharma AG (Germany) Company Information
13.6.2 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.6.3 INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 INJEX Pharma AG (Germany) Main Business Overview
13.6.5 INJEX Pharma AG (Germany) Latest Developments
13.7 National Medical Products Inc. (US)
13.7.1 National Medical Products Inc. (US) Company Information
13.7.2 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.7.3 National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 National Medical Products Inc. (US) Main Business Overview
13.7.5 National Medical Products Inc. (US) Latest Developments
13.8 Valeritas, Inc. (US)
13.8.1 Valeritas, Inc. (US) Company Information
13.8.2 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.8.3 Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Valeritas, Inc. (US) Main Business Overview
13.8.5 Valeritas, Inc. (US) Latest Developments
13.9 European Pharma Group (Netherland)
13.9.1 European Pharma Group (Netherland) Company Information
13.9.2 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.9.3 European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 European Pharma Group (Netherland) Main Business Overview
13.9.5 European Pharma Group (Netherland) Latest Developments
13.10 PenJet Corporation (U.S)
13.10.1 PenJet Corporation (U.S) Company Information
13.10.2 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.10.3 PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 PenJet Corporation (U.S) Main Business Overview
13.10.5 PenJet Corporation (U.S) Latest Developments
13.11 Crossject SA (France)
13.11.1 Crossject SA (France) Company Information
13.11.2 Crossject SA (France) Needle-Free Drug Injection Systems Product Portfolios and Specifications
13.11.3 Crossject SA (France) Needle-Free Drug Injection Systems Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Crossject SA (France) Main Business Overview
13.11.5 Crossject SA (France) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Needle-Free Drug Injection Systems Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Needle-Free Drug Injection Systems Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Jet-Based Needle-Free Injectors
Table 4. Major Players of Spring-Based Needle-Free Injectors
Table 5. Major Players of Laser-Powered Needle-Free Injectors
Table 6. Major Players of Vibration-Based Needle-Free Injectors
Table 7. Global Needle-Free Drug Injection Systems Sales by Type (2019-2024) & (K Units)
Table 8. Global Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Table 9. Global Needle-Free Drug Injection Systems Revenue by Type (2019-2024) & ($ million)
Table 10. Global Needle-Free Drug Injection Systems Revenue Market Share by Type (2019-2024)
Table 11. Global Needle-Free Drug Injection Systems Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 13. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Table 14. Global Needle-Free Drug Injection Systems Revenue by Application (2019-2024)
Table 15. Global Needle-Free Drug Injection Systems Revenue Market Share by Application (2019-2024)
Table 16. Global Needle-Free Drug Injection Systems Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Needle-Free Drug Injection Systems Sales by Company (2019-2024) & (K Units)
Table 18. Global Needle-Free Drug Injection Systems Sales Market Share by Company (2019-2024)
Table 19. Global Needle-Free Drug Injection Systems Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Needle-Free Drug Injection Systems Revenue Market Share by Company (2019-2024)
Table 21. Global Needle-Free Drug Injection Systems Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Needle-Free Drug Injection Systems Producing Area Distribution and Sales Area
Table 23. Players Needle-Free Drug Injection Systems Products Offered
Table 24. Needle-Free Drug Injection Systems Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Needle-Free Drug Injection Systems Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Needle-Free Drug Injection Systems Sales Market Share Geographic Region (2019-2024)
Table 29. Global Needle-Free Drug Injection Systems Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Needle-Free Drug Injection Systems Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Needle-Free Drug Injection Systems Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Needle-Free Drug Injection Systems Sales Market Share by Country/Region (2019-2024)
Table 33. Global Needle-Free Drug Injection Systems Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Needle-Free Drug Injection Systems Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 36. Americas Needle-Free Drug Injection Systems Sales Market Share by Country (2019-2024)
Table 37. Americas Needle-Free Drug Injection Systems Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Needle-Free Drug Injection Systems Revenue Market Share by Country (2019-2024)
Table 39. Americas Needle-Free Drug Injection Systems Sales by Type (2019-2024) & (K Units)
Table 40. Americas Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 41. APAC Needle-Free Drug Injection Systems Sales by Region (2019-2024) & (K Units)
Table 42. APAC Needle-Free Drug Injection Systems Sales Market Share by Region (2019-2024)
Table 43. APAC Needle-Free Drug Injection Systems Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Needle-Free Drug Injection Systems Revenue Market Share by Region (2019-2024)
Table 45. APAC Needle-Free Drug Injection Systems Sales by Type (2019-2024) & (K Units)
Table 46. APAC Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 47. Europe Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 48. Europe Needle-Free Drug Injection Systems Sales Market Share by Country (2019-2024)
Table 49. Europe Needle-Free Drug Injection Systems Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Needle-Free Drug Injection Systems Revenue Market Share by Country (2019-2024)
Table 51. Europe Needle-Free Drug Injection Systems Sales by Type (2019-2024) & (K Units)
Table 52. Europe Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Needle-Free Drug Injection Systems Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Needle-Free Drug Injection Systems Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Needle-Free Drug Injection Systems Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Needle-Free Drug Injection Systems
Table 60. Key Market Challenges & Risks of Needle-Free Drug Injection Systems
Table 61. Key Industry Trends of Needle-Free Drug Injection Systems
Table 62. Needle-Free Drug Injection Systems Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Needle-Free Drug Injection Systems Distributors List
Table 65. Needle-Free Drug Injection Systems Customer List
Table 66. Global Needle-Free Drug Injection Systems Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Needle-Free Drug Injection Systems Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Needle-Free Drug Injection Systems Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Needle-Free Drug Injection Systems Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Needle-Free Drug Injection Systems Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Needle-Free Drug Injection Systems Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Needle-Free Drug Injection Systems Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Needle-Free Drug Injection Systems Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Needle-Free Drug Injection Systems Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Needle-Free Drug Injection Systems Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Needle-Free Drug Injection Systems Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Antares Pharma, Inc. (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 81. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 82. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Antares Pharma, Inc. (US) Main Business
Table 84. Antares Pharma, Inc. (US) Latest Developments
Table 85. Endo International plc (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 86. Endo International plc (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 87. Endo International plc (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Endo International plc (US) Main Business
Table 89. Endo International plc (US) Latest Developments
Table 90. PharmaJet (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 91. PharmaJet (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 92. PharmaJet (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. PharmaJet (U.S) Main Business
Table 94. PharmaJet (U.S) Latest Developments
Table 95. Bioject Medical Technologies Inc. (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 96. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 97. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Bioject Medical Technologies Inc. (U.S) Main Business
Table 99. Bioject Medical Technologies Inc. (U.S) Latest Developments
Table 100. Medical International Technology, Inc. (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 101. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 102. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Medical International Technology, Inc. (U.S) Main Business
Table 104. Medical International Technology, Inc. (U.S) Latest Developments
Table 105. INJEX Pharma AG (Germany) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 106. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 107. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. INJEX Pharma AG (Germany) Main Business
Table 109. INJEX Pharma AG (Germany) Latest Developments
Table 110. National Medical Products Inc. (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 111. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 112. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. National Medical Products Inc. (US) Main Business
Table 114. National Medical Products Inc. (US) Latest Developments
Table 115. Valeritas, Inc. (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 116. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 117. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Valeritas, Inc. (US) Main Business
Table 119. Valeritas, Inc. (US) Latest Developments
Table 120. European Pharma Group (Netherland) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 121. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 122. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. European Pharma Group (Netherland) Main Business
Table 124. European Pharma Group (Netherland) Latest Developments
Table 125. PenJet Corporation (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 126. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 127. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. PenJet Corporation (U.S) Main Business
Table 129. PenJet Corporation (U.S) Latest Developments
Table 130. Crossject SA (France) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 131. Crossject SA (France) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 132. Crossject SA (France) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Crossject SA (France) Main Business
Table 134. Crossject SA (France) Latest Developments
Table 1. Needle-Free Drug Injection Systems Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Needle-Free Drug Injection Systems Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Jet-Based Needle-Free Injectors
Table 4. Major Players of Spring-Based Needle-Free Injectors
Table 5. Major Players of Laser-Powered Needle-Free Injectors
Table 6. Major Players of Vibration-Based Needle-Free Injectors
Table 7. Global Needle-Free Drug Injection Systems Sales by Type (2019-2024) & (K Units)
Table 8. Global Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Table 9. Global Needle-Free Drug Injection Systems Revenue by Type (2019-2024) & ($ million)
Table 10. Global Needle-Free Drug Injection Systems Revenue Market Share by Type (2019-2024)
Table 11. Global Needle-Free Drug Injection Systems Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 13. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Table 14. Global Needle-Free Drug Injection Systems Revenue by Application (2019-2024)
Table 15. Global Needle-Free Drug Injection Systems Revenue Market Share by Application (2019-2024)
Table 16. Global Needle-Free Drug Injection Systems Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Needle-Free Drug Injection Systems Sales by Company (2019-2024) & (K Units)
Table 18. Global Needle-Free Drug Injection Systems Sales Market Share by Company (2019-2024)
Table 19. Global Needle-Free Drug Injection Systems Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Needle-Free Drug Injection Systems Revenue Market Share by Company (2019-2024)
Table 21. Global Needle-Free Drug Injection Systems Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Needle-Free Drug Injection Systems Producing Area Distribution and Sales Area
Table 23. Players Needle-Free Drug Injection Systems Products Offered
Table 24. Needle-Free Drug Injection Systems Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Needle-Free Drug Injection Systems Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Needle-Free Drug Injection Systems Sales Market Share Geographic Region (2019-2024)
Table 29. Global Needle-Free Drug Injection Systems Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Needle-Free Drug Injection Systems Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Needle-Free Drug Injection Systems Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Needle-Free Drug Injection Systems Sales Market Share by Country/Region (2019-2024)
Table 33. Global Needle-Free Drug Injection Systems Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Needle-Free Drug Injection Systems Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 36. Americas Needle-Free Drug Injection Systems Sales Market Share by Country (2019-2024)
Table 37. Americas Needle-Free Drug Injection Systems Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Needle-Free Drug Injection Systems Revenue Market Share by Country (2019-2024)
Table 39. Americas Needle-Free Drug Injection Systems Sales by Type (2019-2024) & (K Units)
Table 40. Americas Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 41. APAC Needle-Free Drug Injection Systems Sales by Region (2019-2024) & (K Units)
Table 42. APAC Needle-Free Drug Injection Systems Sales Market Share by Region (2019-2024)
Table 43. APAC Needle-Free Drug Injection Systems Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Needle-Free Drug Injection Systems Revenue Market Share by Region (2019-2024)
Table 45. APAC Needle-Free Drug Injection Systems Sales by Type (2019-2024) & (K Units)
Table 46. APAC Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 47. Europe Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 48. Europe Needle-Free Drug Injection Systems Sales Market Share by Country (2019-2024)
Table 49. Europe Needle-Free Drug Injection Systems Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Needle-Free Drug Injection Systems Revenue Market Share by Country (2019-2024)
Table 51. Europe Needle-Free Drug Injection Systems Sales by Type (2019-2024) & (K Units)
Table 52. Europe Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Needle-Free Drug Injection Systems Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Needle-Free Drug Injection Systems Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Needle-Free Drug Injection Systems Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Needle-Free Drug Injection Systems Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Needle-Free Drug Injection Systems Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Needle-Free Drug Injection Systems
Table 60. Key Market Challenges & Risks of Needle-Free Drug Injection Systems
Table 61. Key Industry Trends of Needle-Free Drug Injection Systems
Table 62. Needle-Free Drug Injection Systems Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Needle-Free Drug Injection Systems Distributors List
Table 65. Needle-Free Drug Injection Systems Customer List
Table 66. Global Needle-Free Drug Injection Systems Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Needle-Free Drug Injection Systems Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Needle-Free Drug Injection Systems Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Needle-Free Drug Injection Systems Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Needle-Free Drug Injection Systems Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Needle-Free Drug Injection Systems Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Needle-Free Drug Injection Systems Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Needle-Free Drug Injection Systems Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Needle-Free Drug Injection Systems Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Needle-Free Drug Injection Systems Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Needle-Free Drug Injection Systems Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Needle-Free Drug Injection Systems Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Antares Pharma, Inc. (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 81. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 82. Antares Pharma, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Antares Pharma, Inc. (US) Main Business
Table 84. Antares Pharma, Inc. (US) Latest Developments
Table 85. Endo International plc (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 86. Endo International plc (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 87. Endo International plc (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Endo International plc (US) Main Business
Table 89. Endo International plc (US) Latest Developments
Table 90. PharmaJet (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 91. PharmaJet (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 92. PharmaJet (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. PharmaJet (U.S) Main Business
Table 94. PharmaJet (U.S) Latest Developments
Table 95. Bioject Medical Technologies Inc. (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 96. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 97. Bioject Medical Technologies Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Bioject Medical Technologies Inc. (U.S) Main Business
Table 99. Bioject Medical Technologies Inc. (U.S) Latest Developments
Table 100. Medical International Technology, Inc. (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 101. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 102. Medical International Technology, Inc. (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Medical International Technology, Inc. (U.S) Main Business
Table 104. Medical International Technology, Inc. (U.S) Latest Developments
Table 105. INJEX Pharma AG (Germany) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 106. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 107. INJEX Pharma AG (Germany) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. INJEX Pharma AG (Germany) Main Business
Table 109. INJEX Pharma AG (Germany) Latest Developments
Table 110. National Medical Products Inc. (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 111. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 112. National Medical Products Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. National Medical Products Inc. (US) Main Business
Table 114. National Medical Products Inc. (US) Latest Developments
Table 115. Valeritas, Inc. (US) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 116. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 117. Valeritas, Inc. (US) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Valeritas, Inc. (US) Main Business
Table 119. Valeritas, Inc. (US) Latest Developments
Table 120. European Pharma Group (Netherland) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 121. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 122. European Pharma Group (Netherland) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. European Pharma Group (Netherland) Main Business
Table 124. European Pharma Group (Netherland) Latest Developments
Table 125. PenJet Corporation (U.S) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 126. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 127. PenJet Corporation (U.S) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. PenJet Corporation (U.S) Main Business
Table 129. PenJet Corporation (U.S) Latest Developments
Table 130. Crossject SA (France) Basic Information, Needle-Free Drug Injection Systems Manufacturing Base, Sales Area and Its Competitors
Table 131. Crossject SA (France) Needle-Free Drug Injection Systems Product Portfolios and Specifications
Table 132. Crossject SA (France) Needle-Free Drug Injection Systems Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Crossject SA (France) Main Business
Table 134. Crossject SA (France) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Needle-Free Drug Injection Systems
Figure 2. Needle-Free Drug Injection Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Needle-Free Drug Injection Systems Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Needle-Free Drug Injection Systems Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Needle-Free Drug Injection Systems Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Jet-Based Needle-Free Injectors
Figure 10. Product Picture of Spring-Based Needle-Free Injectors
Figure 11. Product Picture of Laser-Powered Needle-Free Injectors
Figure 12. Product Picture of Vibration-Based Needle-Free Injectors
Figure 13. Global Needle-Free Drug Injection Systems Sales Market Share by Type in 2023
Figure 14. Global Needle-Free Drug Injection Systems Revenue Market Share by Type (2019-2024)
Figure 15. Needle-Free Drug Injection Systems Consumed in Hospitals and Clinics
Figure 16. Global Needle-Free Drug Injection Systems Market: Hospitals and Clinics (2019-2024) & (K Units)
Figure 17. Needle-Free Drug Injection Systems Consumed in Homecare Settings
Figure 18. Global Needle-Free Drug Injection Systems Market: Homecare Settings (2019-2024) & (K Units)
Figure 19. Needle-Free Drug Injection Systems Consumed in Research Laboratories
Figure 20. Global Needle-Free Drug Injection Systems Market: Research Laboratories (2019-2024) & (K Units)
Figure 21. Needle-Free Drug Injection Systems Consumed in Pharmaceutical and Biotechnology companies
Figure 22. Global Needle-Free Drug Injection Systems Market: Pharmaceutical and Biotechnology companies (2019-2024) & (K Units)
Figure 23. Needle-Free Drug Injection Systems Consumed in Other End Users
Figure 24. Global Needle-Free Drug Injection Systems Market: Other End Users (2019-2024) & (K Units)
Figure 25. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2023)
Figure 26. Global Needle-Free Drug Injection Systems Revenue Market Share by Application in 2023
Figure 27. Needle-Free Drug Injection Systems Sales Market by Company in 2023 (K Units)
Figure 28. Global Needle-Free Drug Injection Systems Sales Market Share by Company in 2023
Figure 29. Needle-Free Drug Injection Systems Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Needle-Free Drug Injection Systems Revenue Market Share by Company in 2023
Figure 31. Global Needle-Free Drug Injection Systems Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Needle-Free Drug Injection Systems Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Needle-Free Drug Injection Systems Sales 2019-2024 (K Units)
Figure 34. Americas Needle-Free Drug Injection Systems Revenue 2019-2024 ($ Millions)
Figure 35. APAC Needle-Free Drug Injection Systems Sales 2019-2024 (K Units)
Figure 36. APAC Needle-Free Drug Injection Systems Revenue 2019-2024 ($ Millions)
Figure 37. Europe Needle-Free Drug Injection Systems Sales 2019-2024 (K Units)
Figure 38. Europe Needle-Free Drug Injection Systems Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Needle-Free Drug Injection Systems Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Needle-Free Drug Injection Systems Revenue 2019-2024 ($ Millions)
Figure 41. Americas Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 42. Americas Needle-Free Drug Injection Systems Revenue Market Share by Country in 2023
Figure 43. Americas Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Figure 44. Americas Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Figure 45. United States Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Needle-Free Drug Injection Systems Sales Market Share by Region in 2023
Figure 50. APAC Needle-Free Drug Injection Systems Revenue Market Share by Regions in 2023
Figure 51. APAC Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Figure 52. APAC Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Figure 53. China Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 61. Europe Needle-Free Drug Injection Systems Revenue Market Share by Country in 2023
Figure 62. Europe Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Figure 63. Europe Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Figure 64. Germany Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Needle-Free Drug Injection Systems Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Figure 73. Egypt Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Needle-Free Drug Injection Systems in 2023
Figure 79. Manufacturing Process Analysis of Needle-Free Drug Injection Systems
Figure 80. Industry Chain Structure of Needle-Free Drug Injection Systems
Figure 81. Channels of Distribution
Figure 82. Global Needle-Free Drug Injection Systems Sales Market Forecast by Region (2025-2030)
Figure 83. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Needle-Free Drug Injection Systems
Figure 2. Needle-Free Drug Injection Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Needle-Free Drug Injection Systems Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Needle-Free Drug Injection Systems Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Needle-Free Drug Injection Systems Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Jet-Based Needle-Free Injectors
Figure 10. Product Picture of Spring-Based Needle-Free Injectors
Figure 11. Product Picture of Laser-Powered Needle-Free Injectors
Figure 12. Product Picture of Vibration-Based Needle-Free Injectors
Figure 13. Global Needle-Free Drug Injection Systems Sales Market Share by Type in 2023
Figure 14. Global Needle-Free Drug Injection Systems Revenue Market Share by Type (2019-2024)
Figure 15. Needle-Free Drug Injection Systems Consumed in Hospitals and Clinics
Figure 16. Global Needle-Free Drug Injection Systems Market: Hospitals and Clinics (2019-2024) & (K Units)
Figure 17. Needle-Free Drug Injection Systems Consumed in Homecare Settings
Figure 18. Global Needle-Free Drug Injection Systems Market: Homecare Settings (2019-2024) & (K Units)
Figure 19. Needle-Free Drug Injection Systems Consumed in Research Laboratories
Figure 20. Global Needle-Free Drug Injection Systems Market: Research Laboratories (2019-2024) & (K Units)
Figure 21. Needle-Free Drug Injection Systems Consumed in Pharmaceutical and Biotechnology companies
Figure 22. Global Needle-Free Drug Injection Systems Market: Pharmaceutical and Biotechnology companies (2019-2024) & (K Units)
Figure 23. Needle-Free Drug Injection Systems Consumed in Other End Users
Figure 24. Global Needle-Free Drug Injection Systems Market: Other End Users (2019-2024) & (K Units)
Figure 25. Global Needle-Free Drug Injection Systems Sales Market Share by Application (2023)
Figure 26. Global Needle-Free Drug Injection Systems Revenue Market Share by Application in 2023
Figure 27. Needle-Free Drug Injection Systems Sales Market by Company in 2023 (K Units)
Figure 28. Global Needle-Free Drug Injection Systems Sales Market Share by Company in 2023
Figure 29. Needle-Free Drug Injection Systems Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Needle-Free Drug Injection Systems Revenue Market Share by Company in 2023
Figure 31. Global Needle-Free Drug Injection Systems Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Needle-Free Drug Injection Systems Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Needle-Free Drug Injection Systems Sales 2019-2024 (K Units)
Figure 34. Americas Needle-Free Drug Injection Systems Revenue 2019-2024 ($ Millions)
Figure 35. APAC Needle-Free Drug Injection Systems Sales 2019-2024 (K Units)
Figure 36. APAC Needle-Free Drug Injection Systems Revenue 2019-2024 ($ Millions)
Figure 37. Europe Needle-Free Drug Injection Systems Sales 2019-2024 (K Units)
Figure 38. Europe Needle-Free Drug Injection Systems Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Needle-Free Drug Injection Systems Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Needle-Free Drug Injection Systems Revenue 2019-2024 ($ Millions)
Figure 41. Americas Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 42. Americas Needle-Free Drug Injection Systems Revenue Market Share by Country in 2023
Figure 43. Americas Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Figure 44. Americas Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Figure 45. United States Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Needle-Free Drug Injection Systems Sales Market Share by Region in 2023
Figure 50. APAC Needle-Free Drug Injection Systems Revenue Market Share by Regions in 2023
Figure 51. APAC Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Figure 52. APAC Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Figure 53. China Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 61. Europe Needle-Free Drug Injection Systems Revenue Market Share by Country in 2023
Figure 62. Europe Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Figure 63. Europe Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Figure 64. Germany Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Needle-Free Drug Injection Systems Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Needle-Free Drug Injection Systems Sales Market Share by Application (2019-2024)
Figure 73. Egypt Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Needle-Free Drug Injection Systems Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Needle-Free Drug Injection Systems in 2023
Figure 79. Manufacturing Process Analysis of Needle-Free Drug Injection Systems
Figure 80. Industry Chain Structure of Needle-Free Drug Injection Systems
Figure 81. Channels of Distribution
Figure 82. Global Needle-Free Drug Injection Systems Sales Market Forecast by Region (2025-2030)
Figure 83. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Needle-Free Drug Injection Systems Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Needle-Free Drug Injection Systems Revenue Market Share Forecast by Application (2025-2030)
More Publications
Global Chromhidrosis Treatment Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
63 pages
Global Single Cell Sequencing Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
108 pages
Global Pancreatic and Bile Duct Stone Management Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
100 pages
Global Rapid Diagnostics Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
March 2023
122 pages
Global PECAM-1 Antibody Market Growth 2024-2030
US$ 3,660.00
December 2024
150 pages
